CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $202,973 | -28.7% | 48,327 | +2.0% | 0.00% | -50.0% |
| Q4 2022 | $284,664 | +2.8% | 47,365 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $277,000 | +6.9% | 47,537 | +9.7% | 0.00% | 0.0% |
| Q2 2022 | $259,000 | +709.4% | 43,353 | +33.1% | 0.00% | – |
| Q1 2019 | $32,000 | +28.0% | 32,574 | -3.1% | 0.00% | – |
| Q4 2018 | $25,000 | -65.8% | 33,631 | -0.8% | 0.00% | – |
| Q3 2018 | $73,000 | -56.0% | 33,889 | +1.8% | 0.00% | -100.0% |
| Q2 2018 | $166,000 | – | 33,278 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,904,400 | $3,355,000 | 2.31% |
| BVF INC/IL | 6,929,690 | $5,955,000 | 0.65% |
| CAXTON CORP | 324,452 | $279,000 | 0.32% |
| NEA Management Company, LLC | 3,750,000 | $3,222,000 | 0.23% |
| Orbimed Advisors | 5,000,000 | $4,297,000 | 0.07% |
| Fosun International Ltd | 459,274 | $390,000 | 0.03% |
| Paloma Partners Management Co | 229,800 | $197,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 127,602 | $110,000 | 0.00% |
| LMR Partners LLP | 54,931 | $47,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,495 | $15,000 | 0.00% |